Literature DB >> 27341992

A rare DNA contact mutation in cancer confers p53 gain-of-function and tumor cell survival via TNFAIP8 induction.

Jessica A Monteith1, Hestia Mellert2, Morgan A Sammons3, Laudita A Kuswanto4, Stephen M Sykes5, Lois Resnick-Silverman6, James J Manfredi7, Shelley L Berger8, Steven B McMahon9.   

Abstract

The p53 tumor suppressor gene encodes a sequence-specific transcription factor. Mutations in the coding sequence of p53 occur frequently in human cancer and often result in single amino acid substitutions (missense mutations) in the DNA binding domain (DBD), blocking normal tumor suppressive functions. In addition to the loss of canonical functions, some missense mutations in p53 confer gain-of-function (GOF) activities to tumor cells. While many missense mutations in p53 cluster at six "hotspot" amino acids, the majority of mutations in human cancer occur elsewhere in the DBD and at a much lower frequency. We report here that mutations at K120, a non-hotspot DNA contact residue, confer p53 with the previously unrecognized ability to bind and activate the transcription of the pro-survival TNFAIP8 gene. Mutant K120 p53 binds the TNFAIP8 locus at a cryptic p53 response element that is not occupied by wild-type p53. Furthermore, induction of TNFAIP8 is critical for the evasion of apoptosis by tumor cells expressing the K120R variant of p53. These findings identify induction of pro-survival targets as a mechanism of gain-of-function activity for mutant p53 and will likely broaden our understanding of this phenomenon beyond the limited number of GOF activities currently reported for hotspot mutants. Published by Elsevier B.V.

Entities:  

Keywords:  Gain of function; Mutant p53; Pro-survival; TNFα

Mesh:

Substances:

Year:  2016        PMID: 27341992      PMCID: PMC5423199          DOI: 10.1016/j.molonc.2016.05.007

Source DB:  PubMed          Journal:  Mol Oncol        ISSN: 1574-7891            Impact factor:   6.603


  47 in total

1.  Histone H3K27ac separates active from poised enhancers and predicts developmental state.

Authors:  Menno P Creyghton; Albert W Cheng; G Grant Welstead; Tristan Kooistra; Bryce W Carey; Eveline J Steine; Jacob Hanna; Michael A Lodato; Garrett M Frampton; Phillip A Sharp; Laurie A Boyer; Richard A Young; Rudolf Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-24       Impact factor: 11.205

2.  The UCSC Known Genes.

Authors:  Fan Hsu; W James Kent; Hiram Clawson; Robert M Kuhn; Mark Diekhans; David Haussler
Journal:  Bioinformatics       Date:  2006-02-24       Impact factor: 6.937

3.  TNFAIP8 overexpression is associated with platinum resistance in epithelial ovarian cancers with optimal cytoreduction.

Authors:  Tianbo Liu; Bairong Xia; Yanhong Lu; Ye Xu; Ge Lou
Journal:  Hum Pathol       Date:  2014-02-20       Impact factor: 3.466

4.  Mutational analysis of the p53 core domain L1 loop.

Authors:  Andrew Zupnick; Carol Prives
Journal:  J Biol Chem       Date:  2006-05-10       Impact factor: 5.157

5.  Structural effects of the L145Q, V157F, and R282W cancer-associated mutations in the p53 DNA-binding core domain.

Authors:  Sara Calhoun; Valerie Daggett
Journal:  Biochemistry       Date:  2011-05-17       Impact factor: 3.162

Review 6.  Transcription regulation by mutant p53.

Authors:  L Weisz; M Oren; V Rotter
Journal:  Oncogene       Date:  2007-04-02       Impact factor: 9.867

7.  Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities.

Authors:  Sven Heinz; Christopher Benner; Nathanael Spann; Eric Bertolino; Yin C Lin; Peter Laslo; Jason X Cheng; Cornelis Murre; Harinder Singh; Christopher K Glass
Journal:  Mol Cell       Date:  2010-05-28       Impact factor: 17.970

8.  Structural basis for understanding oncogenic p53 mutations and designing rescue drugs.

Authors:  Andreas C Joerger; Hwee Ching Ang; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-02       Impact factor: 11.205

9.  Unequal prognostic potentials of p53 gain-of-function mutations in human cancers associate with drug-metabolizing activity.

Authors:  J Xu; J Wang; Y Hu; J Qian; B Xu; H Chen; W Zou; J-Y Fang
Journal:  Cell Death Dis       Date:  2014-03-06       Impact factor: 8.469

10.  An integrated encyclopedia of DNA elements in the human genome.

Authors: 
Journal:  Nature       Date:  2012-09-06       Impact factor: 49.962

View more
  14 in total

1.  The RanBP2/RanGAP1-SUMO complex gates β-arrestin2 nuclear entry to regulate the Mdm2-p53 signaling axis.

Authors:  Elodie Blondel-Tepaz; Marie Leverve; Badr Sokrat; Justine S Paradis; Milena Kosic; Kusumika Saha; Cédric Auffray; Evelyne Lima-Fernandes; Alessia Zamborlini; Anne Poupon; Louis Gaboury; Jane Findlay; George S Baillie; Hervé Enslen; Michel Bouvier; Stéphane Angers; Stefano Marullo; Mark G H Scott
Journal:  Oncogene       Date:  2021-03-01       Impact factor: 9.867

2.  Dual Targeting of EGFR and IGF1R in the TNFAIP8 Knockdown Non-Small Cell Lung Cancer Cells.

Authors:  Timothy F Day; Bhaskar V S Kallakury; Jeffrey S Ross; Olga Voronel; Shantashri Vaidya; Christine E Sheehan; Usha N Kasid
Journal:  Mol Cancer Res       Date:  2019-01-15       Impact factor: 5.852

3.  K120R mutation inactivates p53 by creating an aberrant splice site leading to nonsense-mediated mRNA decay.

Authors:  Seo-Young Lee; Jung-Hyun Park; Sangkyun Jeong; Bu-Yeo Kim; Yong-Kook Kang; Yang Xu; Sun-Ku Chung
Journal:  Oncogene       Date:  2018-10-22       Impact factor: 9.867

4.  Network-guided prediction of aromatase inhibitor response in breast cancer.

Authors:  Matthew Ruffalo; Roby Thomas; Jian Chen; Adrian V Lee; Steffi Oesterreich; Ziv Bar-Joseph
Journal:  PLoS Comput Biol       Date:  2019-02-11       Impact factor: 4.475

5.  Comparison of genotoxic versus nongenotoxic stabilization of p53 provides insight into parallel stress-responsive transcriptional networks.

Authors:  Allison N Catizone; Charly Ryan Good; Katherine A Alexander; Shelley L Berger; Morgan A Sammons
Journal:  Cell Cycle       Date:  2019-04-09       Impact factor: 4.534

Review 6.  Oncogenic Role of Tumor Necrosis Factor α-Induced Protein 8 (TNFAIP8).

Authors:  Suryakant Niture; Xialan Dong; Elena Arthur; Uchechukwu Chimeh; Samiksha S Niture; Weifan Zheng; Deepak Kumar
Journal:  Cells       Date:  2018-12-24       Impact factor: 6.600

7.  Inhibition of Aurora A enhances radiosensitivity in selected lung cancer cell lines.

Authors:  Ningbo Liu; Yong Antican Wang; Yunguang Sun; Jeffrey Ecsedy; Jifeng Sun; Xue Li; Ping Wang
Journal:  Respir Res       Date:  2019-10-23

Review 8.  Tumor Necrosis Factor-α Induced Protein 8: Pathophysiology, Clinical Significance, and Regulatory Mechanism.

Authors:  Lei Zhang; Ran Liu; Ying-Yi Luan; Yong-Ming Yao
Journal:  Int J Biol Sci       Date:  2018-03-10       Impact factor: 6.580

9.  LncRNA H19 promotes triple-negative breast cancer cells invasion and metastasis through the p53/TNFAIP8 pathway.

Authors:  Yang Li; Hong-Yu Ma; Xiao-Wei Hu; Yuan-Yuan Qu; Xin Wen; Yu Zhang; Qing-Yong Xu
Journal:  Cancer Cell Int       Date:  2020-05-29       Impact factor: 5.722

Review 10.  TIPE Family of Proteins and Its Implications in Different Chronic Diseases.

Authors:  Devivasha Bordoloi; Kishore Banik; Bano Shabnam; Ganesan Padmavathi; Javadi Monisha; Frank Arfuso; Arunasalam Dharmarajan; Xinliang Mao; Lina H K Lim; Lingzhi Wang; Lu Fan; Kam Man Hui; Alan Prem Kumar; Gautam Sethi; Ajaikumar B Kunnumakkara
Journal:  Int J Mol Sci       Date:  2018-09-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.